Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tongfang Pharmaceutical Group is a large-scale pharmaceutical conglomerate based in China, operating as a core subsidiary of Tongfang Co., Ltd. under the China National Nuclear Corporation (CNNC). The company specializes in the research, development, manufacturing, and distribution of a diverse range of healthcare products, including chemical generics, traditional Chinese medicines (TCM), and active pharmaceutical ingredients (APIs). Its extensive product portfolio addresses critical therapeutic areas such as cardiovascular diseases, infectious diseases, gastrointestinal disorders, and oncology. Tongfang Pharmaceutical maintains several high-standard manufacturing facilities, including major bases in Beijing and Chifeng, which are GMP-certified to produce various dosage forms like tablets, capsules, and large-volume parenterals. The group is recognized for its integration of modern pharmaceutical technology with traditional medicinal practices, serving both domestic Chinese markets and international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tongfang Pharmaceutical Group.